Peter Christey's guest appearances

Peter Christey

Finding Genius Podcast

FutureTech Podcast

Marc Guell

Arvind Gupta

Jan Vijg

Daniel Gartenberg

Brianna Stubbs

Michael Breus

Sandeep Jain

Billy Price

Emeran Mayer

Jason Wolfe

Denis Noble

Mark Russell

Ron Barshop

Kurt Schmidinger

Ben Atkinson

OwlTail

Peter Christey, PhD, CEO and Co-Founder of GALT (General Automation Lab Technologies), on the web at (galt-inc.com), discusses his work in microbial cultivation. Christey has over 20-years experience commercializing research instruments for a number of complex applications. Prior to his launch of GALT, Christey helmed the DNA Sequencing Business Unit and DNA forensic product line for Life Technologies. Christey discusses his background and how his focus in microbial cultivation in a laboratory setting drove him to develop microbes for use in multiple areas. He explains proteomics applications, microbial diversity, and his company’s platform—detailing how they work to get a pure isolate (a culture of living microorganisms) into culture in the lab in order to study biochemistry and physiology. They strive, primarily, to deliver pure, living isolates to researchers and product developers. Utilizing the GALT technology, entire populations of microbes can be screened efficiently and quickly for low-abundance species or perhaps strains that demonstrate selected characteristics. Estimations have surmised that there are approximately one-trillion microbial species on our planet, but remarkably, less than one percent of the known species have actually been cultured. So many species remain unexplored and we just don’t have any information on them. Christey discusses how isolates are understood, and how scientists can test them. He discusses the microbiome, and the growth media that they use in their research. And he provides extensive information on how bacteria grow, and the requirements that are necessary, including a discussion of symbiotic relationships.

Peter Christey, PhD, CEO and Co-Founder of GALT (General Automation Lab Technologies), on the web at (<a href="http://galt-inc.com" rel="nofollow" target="_blank">galt-inc.com</a>), discusses his work in microbial cultivation. Christey has over 20-years experience commercializing research instruments for a number of complex applications. Prior to his launch of GALT, Christey helmed the DNA Sequencing Business Unit and DNA forensic product line for Life Technologies. Christey discusses his background and how his focus in microbial cultivation in a laboratory setting drove him to develop microbes for use in multiple areas. He explains proteomics applications, <a href="https://www.futuretechpodcast.com/podcasts/bacterial-diversity-meagan-rubel-graduate-student-department-of-genetics-at-the-perelman-school-of-medicine-university-of-pennsylvania-an-anthropological-view-of-the-microbiome/" rel="nofollow" target="_blank">microbial diversity</a>, and his company’s platform—detailing how they work to get a pure isolate (a culture of living microorganisms) into culture in the lab in order to study biochemistry and physiology. They strive, primarily, to deliver pure, living isolates to researchers and product developers. Utilizing the GALT technology, entire populations of microbes can be screened efficiently and quickly for low-abundance species or perhaps strains that demonstrate selected characteristics. Estimations have surmised that there are approximately one-trillion microbial species on our planet, but remarkably, less than one percent of the known species have actually been cultured. So many species remain unexplored and we just don’t have any information on them. Christey discusses how isolates are understood, and how scientists can test them. He discusses the microbiome, and the growth media that they use in their research. And he provides extensive information on how bacteria grow, and the requirements that are necessary, including a discussion of symbiotic relationships.

Microbial Mission – Peter Christey, PhD, CEO and Co-Founder of GALT – Greater Access to Microbes, Transforming Microbiome Research & Product Development

In this podcast, Peter Christey, PhD, CEO of General Automation Lab Technologies, commonly known simply as GALT, provides an overview of his company’s work in the area of microbial cultivation. Christey has two decades of extensive experience commercializing research instruments for complex applications. Christey commercialized new, innovative products for Guava Technologies, as well as the industry leader, Chiron Corporation and also Applied Biosystems. Christey has a bachelor’s degree in biochemistry from the University of Otago in New Zealand, and he earned his PhD in molecular biology from the prestigious University of Cambridge in England. Christey also holds an MBA from INSEAD in Fontainebleau, France. Christey talks about microbial cultivation in a laboratory setting, and how his keen interest in microbes, and their potential, motivated him to develop microbes for expanded use in various areas. He discusses proteomics applications, microbial diversity, and detailed information on pure isolates and how his team studies biochemistry and physiology. GALT delivers living isolates to product developers and researchers. Via his company’s tech, complete populations of microbes can be screened quickly for low-abundance species and to identify strains that show specific characteristics. There are close to one-trillion microbial species on Earth; yet less than one percent of them have been cultured, thus there are infinite numbers of species that have yet to be explored, and the potential information we stand to gain is immense as research expands. Christey discusses the microbiome, and growth media, and he provides extensive information on precisely how bacteria grow, and what is needed for growth, discussing the intricate symbiotic relationships that are exhibited.

In this podcast, Peter Christey, PhD, CEO of General Automation Lab Technologies, commonly known simply as GALT, provides an overview of his company’s work in the area of microbial cultivation. Christey has two decades of extensive experience commercializing research instruments for complex applications. Christey commercialized new, innovative products for Guava Technologies, as well as the industry leader, Chiron Corporation and also Applied Biosystems. Christey has a bachelor’s degree in biochemistry from the University of Otago in New Zealand, and he earned his PhD in molecular biology from the prestigious University of Cambridge in England. Christey also holds an MBA from INSEAD in Fontainebleau, France. Christey talks about microbial cultivation in a laboratory setting, and how his keen interest in microbes, and their potential, motivated him to develop microbes for expanded use in various areas. He discusses proteomics applications, microbial diversity, and detailed information on pure isolates and how his team studies biochemistry and physiology. GALT delivers living isolates to product developers and researchers. Via his company’s tech, complete populations of microbes can be screened quickly for low-abundance species and to identify strains that show specific characteristics. There are close to one-trillion microbial species on Earth; yet less than one percent of them have been cultured, thus there are infinite numbers of species that have yet to be explored, and the potential information we stand to gain is immense as research expands. Christey discusses the <a href="https://www.futuretechhealth.com/podcasts/on-the-inner-workings-of-your-gut-dr-samantha-nazareth-a-clinical-internist-and-gastroenterologist/" rel="nofollow" target="_blank">microbiome</a>, and growth media, and he provides extensive information on precisely how bacteria grow, and what is needed for growth, discussing the intricate symbiotic relationships that are exhibited.

Microbial Matters – Peter Christey, PhD, Co-Founder and CEO of GALT – Microbiome Cultivation and Research